1,141 results on '"Koopman, Miriam"'
Search Results
2. Discovering novel germline genetic variants linked to severe fluoropyrimidine-related toxicity in- and outside DPYD
3. Organoids as a biomarker for personalized treatment in metastatic colorectal cancer: drug screen optimization and correlation with patient response
4. Harnessing the Potential of Real-World Evidence in the Treatment of Colorectal Cancer: Where Do We Stand?
5. The Trial within Cohorts (TwiCs) study design in oncology: Experience and methodological reflections
6. Stromal localization of inactive CD8+ T cells in metastatic mismatch repair deficient colorectal cancer
7. Efficacy and safety in early-phase clinical trials for refractory colorectal cancer: A meta-analysis
8. Use of automated assessment for determining associations of low muscle mass and muscle loss with overall survival in patients with colorectal cancer – A validation study
9. Dietary and lifestyle inflammation scores in relation to colorectal cancer recurrence and all-cause mortality: A longitudinal analysis
10. Survival and patient-reported outcomes of real-world high-risk stage II and stage III colon cancer patients after reduction of adjuvant CAPOX duration from 6 to 3 months
11. Survival of Patients with Deficient Mismatch Repair Versus Proficient Mismatch Repair Metastatic Colorectal Cancer Receiving Curative-Intent Local Treatment of Metastases in a Nationwide Cohort
12. Predicting Benefit From FOLFOXIRI Plus Bevacizumab in Patients With Metastatic Colorectal Cancer
13. Improving sustainability of a patient decision aid for systemic treatment of metastatic colorectal cancer: A qualitative study
14. Prognostic value of liver metastases in colorectal cancer treated by systemic therapy: An ARCAD pooled analysis
15. The Trial within Cohorts (TwiCs) study design in oncology: experience and methodological reflections
16. Primary tumor resection or systemic treatment as palliative treatment for patients with isolated synchronous colorectal cancer peritoneal metastases in a nationwide cohort study
17. Results from the UNITED study: a multicenter study validating the prognostic effect of the tumor–stroma ratio in colon cancer
18. Adjuvant chemotherapy in patients with clinically node-negative but pathologically node-positive rectal cancer in the Netherlands: A retrospective analysis
19. Impact of colorectal cancer screening on survival after metachronous metastasis
20. Comparison of NTRK fusion detection methods in microsatellite-instability-high metastatic colorectal cancer
21. A tailored approach to horizon scanning for cancer medicines
22. Effect of adipose tissue quantity and dysfunction on the risk of cancer in individuals with and without type 2 diabetes
23. ASO Visual Abstract: Survival of Patients with Deficient Mismatch Repair Versus Proficient Mismatch Repair Metastatic Colorectal Cancer Receiving Curative-Intent Local Treatment of Metastases in a Nationwide Cohort
24. First-line systemic treatment strategies in patients with initially unresectable colorectal cancer liver metastases (CAIRO5): an open-label, multicentre, randomised, controlled, phase 3 study from the Dutch Colorectal Cancer Group
25. Long-term Survival Update and Extended RAS Mutational Analysis of the CAIRO2 Trial: Addition of Cetuximab to CAPOX/Bevacizumab in Metastatic Colorectal Cancer
26. Evaluation of an individual feedback report on patient-reported outcomes in the Prospective Dutch ColoRectal Cancer cohort
27. Lymphatic invasion of plakoglobin-dependent tumor cell clusters drives formation of polyclonal lung metastases in colon cancer
28. Long-Term Safety Data on S-1 Administered After Previous Intolerance to Capecitabine-Containing Systemic Treatment for Metastatic Colorectal Cancer
29. Quality of Life and Survival of Metastatic Colorectal Cancer Patients Treated With Trifluridine-Tipiracil (QUALITAS)
30. Clinical Outcomes of Biliary Drainage in Patients with Malignant Biliary Obstruction Caused by Colorectal Cancer Metastases
31. Serum-based measurements of stromal activation through ADAM12 associate with poor prognosis in colorectal cancer
32. Dietary and lifestyle inflammation scores in relation to colorectal cancer recurrence and all-cause mortality: A longitudinal analysis.
33. Associations between low‐ and high‐fat dairy intake and recurrence risk in people with stage I–III colorectal cancer differ by sex and primary tumour location.
34. Comparing Modeling Approaches for Discrete Event Simulations With Competing Risks Based on Censored Individual Patient Data: A Simulation Study and Illustration in Colorectal Cancer
35. Personalizing Survival Predictions in Advanced Colorectal Cancer: The ARCAD Nomogram Project
36. Results from the UNITED study: a multicenter study validating the prognostic effect of the tumor–stroma ratio in colon cancer
37. Modeling Personalized Adjuvant TreaTment in EaRly stage coloN cancer (PATTERN)
38. Disease recurrence after colorectal cancer surgery in the modern era: a population-based study
39. Clinical outcomes of biliary drainage of malignant biliary obstruction due to colorectal cancer metastases: A systematic review
40. Survival and patient-reported outcomes of real-world high-risk stage II and stage III colon cancer patients after reduction of adjuvant CAPOX duration from 6 to 3 months
41. Efficacy-effectiveness analysis on survival in a population-based real-world study of BRAF-mutated metastatic colorectal cancer patients treated with encorafenib-cetuximab
42. Prognostic value of liver metastases in colorectal cancer treated by systemic therapy: An ARCAD pooled analysis
43. Oncologic outcomes of screen-detected and non-screen-detected T1 colorectal cancers
44. Organoids as a biomarker for personalized treatment in metastatic colorectal cancer: drug screen optimization and correlation with patient response
45. Determinants of Physical Activity among Patients with Colorectal Cancer: From Diagnosis to 5 Years after Diagnosis
46. Improving sustainability of a patient decision aid for systemic treatment of metastatic colorectal cancer: A qualitative study
47. Discovering novel germline genetic variants linked to severe fluoropyrimidine-related toxicity in- and outside DPYD
48. Early evaluation of the effectiveness and cost-effectiveness of ctDNA-guided selection for adjuvant chemotherapy in stage II colon cancer
49. Use of automated assessment for determining associations of low muscle mass and muscle loss with overall survival in patients with colorectal cancer – A validation study
50. Predicting Benefit From FOLFOXIRI Plus Bevacizumab in Patients With Metastatic Colorectal Cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.